FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Warns 2 Firms Selling Supplements with Tianeptine

FDA warns two companies selling dietary supplements containing tianeptine.

Medical Devices

Beckman Coulter Cytometer Recall is Class 1

FDA classifies as Class 1 a Beckman Coulter recall of two models of flow cytometers due to an electrical circuit error.

Medical Devices

FDA Wants to Be 1st to Find Device Safety Signals

FDA commissioner Scott Gottlieb and CDRH director Jeffrey Shuren discuss steps being taken to ensure that FDA is consistently the first regulatory age...

Medical Devices

SIG Medical 510(k) Cleared for AdvantageRib Anterior System

FDA clears a SIG Medical 510(k) for its AdvantageRib Anterior System, intended for the fixation, stabilization, and fusion of rib fractures and osteot...

Federal Register

47 Drugs Listed Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that 47 drug products it is listing were not withdrawn from sale for reasons of safety or effectiveness.

Human Drugs

FDA Meeting to Address Drug Shortages

FDA and Duke-Margolis Health Policy Center plan an 11/27 public meeting to seek stakeholder input on long-term solutions to address the drug shortage ...

Human Drugs

FDA Approval Expands Label for Novartis Promacta

FDA approves an expanded label for Novartis Promacta (eltrombopag) to include first-line treatment for adults and pediatric patients two years and old...

Human Drugs

Safety Alert on Pharm D Solutions Products

FDA alerts health care professionals and patients not to use drug products produced and distributed by Pharm D Solutions (Houston, TX) due to lack of ...

FDA General

Qualified Claim on Coronary Heart Disease for Oils

FDA responds to a petition to allow a new qualified health claim for edible oils containing high levels of oleic acid, a monounsaturated fat that has ...

Federal Register

Info Collection Extension for Biosimilar Applications

Federal Register notice: FDA submits to OMB an information collection extension for General Licensing Provisions; Section 351(k) Biosimilar Applicatio...